Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

(2018) Al B. Benson et al.   Journal of the National Comprehensive Cancer Network

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

(2018) Stefano Kim et al.   LANCET ONCOLOGY

Systemic Therapies for Advanced Squamous Cell Anal Cancer

(2018) Francesco Sclafani et al.   Current Oncology Reports

Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer

(2018) Erminia Massarelli et al.   JAMA Oncology

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

(2017) Van K Morris et al.   LANCET ONCOLOGY

Platinum‐Fluoropyrimidine and Paclitaxel‐Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients

(2017) Francesco Sclafani et al.   ONCOLOGIST

EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience

(2017) Dae Won Kim et al.   ONCOLOGY

Mitomycin-C+fluoropyrimidines in heavily pretreated metastatic colorectal cancer

(2016) Fausto Petrelli et al.   ANTI-CANCER DRUGS

Epidermal growth factor receptor inhibition in metastatic anal cancer

(2016) Jane E. Rogers et al.   ANTI-CANCER DRUGS

Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review

(2016) Stergios Boussios et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Carboplatin and Paclitaxel Treatment Is Effective in Advanced Anal Cancer

(2014) Richard Kim et al.   ONCOLOGY

Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up

(2014) Robert Glynne-Jones et al.   RADIOTHERAPY AND ONCOLOGY

Systemic treatment and medical management of metastatic squamous cell carcinoma of the head and neck: Review of the literature and proposal for management changes

(2013) Frédéric Peyrade et al.   ORAL ONCOLOGY

Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study

(2012) Eric Francois et al.   JOURNAL OF CHEMOTHERAPY

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

(2012) Leonard L. Gunderson et al.   JOURNAL OF CLINICAL ONCOLOGY

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

(2012) Catherine de Martel et al.   LANCET ONCOLOGY

Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma

(2010) Eun Joo KANG et al.   Asia-Pacific Journal of Clinical Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal

(2008) Jaffer A. Ajani   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION